Related Experiment Video

Updated: May 21, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

MicroRNA control of epithelial-mesenchymal transition and metastasis

Jinsong Zhang1, Li Ma

  • 1Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Cancer Metastasis Reviews
|June 12, 2012
PubMed

Insights

MicroRNAs (miRNAs) are key regulators of cancer metastasis, a major cause of cancer deaths. This review explores how miRNAs influence epithelial-mesenchymal transition (EMT) and metastasis through gene expression regulation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer metastasis is a complex, poorly understood process responsible for the majority of cancer-related deaths.
  • Metastasis involves a series of steps from disseminated tumor cells to macroscopic outgrowth at secondary sites.
  • MicroRNAs (miRNAs) have emerged as critical regulators in cancer progression and metastasis.

Purpose of the Study:

  • To review recent findings on the role of microRNAs (miRNAs) in regulating cancer metastasis.
  • To elucidate the molecular mechanisms by which miRNAs control epithelial-mesenchymal transition (EMT) and metastatic processes.
  • To highlight the significance of miRNAs in understanding and potentially targeting cancer spread.

Main Methods:

  • Literature review of recent scientific studies.
  • Analysis of research on microRNA functions in cancer metastasis.
  • Focus on molecular mechanisms, including gene expression regulation by miRNAs.

Main Results:

  • MicroRNAs (miRNAs) can regulate single or multiple steps of the metastatic cascade.
  • miRNAs exert their function by downregulating the expression of specific target genes.
  • These regulatory roles are crucial in controlling epithelial-mesenchymal transition (EMT), a key process in metastasis.

Conclusions:

  • MicroRNAs play a significant role in regulating cancer metastasis.
  • Understanding miRNA-mediated gene regulation offers insights into the mechanisms of EMT and cancer spread.
  • Targeting miRNAs presents a potential therapeutic strategy for inhibiting metastasis.

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...